Takeda Biopharmaceuticals India Private Limited has been awarded the prestigious Great Place To Work® certification in India for March 2023 – March 2024. The global biopharmaceutical company, previously Baxalta Bioscience India Pvt. Ltd., is renowned for its research and development in Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI).
The Great Place To Work® Institute, a leading global authority on workplace culture, serves organizations across 60 countries, identifying key qualities that define exceptional workplaces. The Institute collaborates with more than 1400 organizations annually across 22 industries in India, supporting the development of High-Trust, High-Performance Cultures.
Takeda’s employees are dedicated to improving patients’ quality of life and working closely with healthcare partners in about 80 countries and regions. The Great Place to Work® certification in India is a recognition of Takeda’s ongoing commitment to fostering a work environment that values employee well-being, professional growth, and alignment with the company’s mission and values.